Cell-free DNA (cfDNA) is a noninvasive and informative disease biomarker, providing relevant information regarding disease characteristics and origins. Its use in clinical diagnostics was previously limited, but recent improvements in automation and high-throughput screening machinery allow scientists to classify cfDNA rapidly in large patient populations.
Download this poster from Tecan to discover how technological innovation enables faster cfDNA-mediated diagnosis.
Top Image Credit:
istock
A neurobiologist, who loves the morphology of cells, turns these shapes into works of art made from wood.
View this Issue
Explore the latest in cell culture supplies, from tried and tested classics to cutting-edge innovative products.
Explore the latest in cell culture supplies, from tried and tested classics to cutting-edge innovative products.
Within the tumor microenvironment, networks of cells and molecular signals form a dynamic landscape that drives disease progression.
Individual NGS methods come with their own pros and cons, but automation optimization solutions exist for all NGS workflows.
This partnership will enable both companies to reach a broader range of customers, including those with more complex and specialized workflows
Submit a cutting-edge product or technology for the chance to be recognized as one of The Scientist’s 2026 Top Innovations.
Biotium's new TyraMax™ Amplification Dyes and Kits are available with the widest selection of colors for spatial analysis
Ten-year Agreement to Provide a Secure, AI-enabled Forensic Laboratory Information Management System Supporting DHS Forensic, Scientific, and Testing Services
